Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT05635266
NCT05635266RecruitingNot Applicable

A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Sanguine Biosciences1 site in 1 country20,000 target enrollmentStarted: October 26, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
20,000
Locations
1
Primary Endpoint
Biospecimen & Clinical Data Collection
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Persons 18 to 85 years of age at the date of informed consent.
  • •If presenting with a history of a specific condition, the diagnosis is confirmable in the medical record or may be confirmed using other forms of verification including self-reporting.
  • •Understands the procedures and requirements of the study by providing written informed consent (or verbal assent if a legally authorized representative will sign the ICF), including consent for authorization for protected health information disclosure.

Exclusion Criteria

  • •Persons younger than 18 years of age or older than 85 years of age at the date of informed consent.
  • •Receipt of blood products 30 days before the study blood draw.
  • •Receipt of an investigational (unapproved) drug 30 days before the study blood draw.
  • •A confirmable diagnosis of any medical condition that would increase potential phlebotomy risks.
  • •Has donated a unit of blood within the last 2 months at the date of informed consent.

Outcomes

Primary Outcomes

Biospecimen & Clinical Data Collection

Time Frame: 10 years

To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Sanguine Biosciences
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Louisville Cooperative Tissue BiorepositoryNormal and Abnormal Tissue
NCT02021916University of Louisville17,499
Terminated
Not Applicable
Biorepository for Precision GenomicsNeoplasms
NCT02587026Indiana University480
Recruiting
Not Applicable
A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research InitiativesRare Diseases
NCT05794217Sanguine Biosciences20,000
Completed
Not Applicable
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsAll Diagnosed Health ConditionsADD/ADHDAtopic Dermatitis EczemaBeta ThalassemiaChronic Kidney DiseasesBreast CancerColorectal CancerCervical CancerBipolar DisorderColon CancerChronic Obstructive Pulmonary DiseaseFacioscapulohumeral Muscular DystrophyG6PD DeficiencyGeneral Anxiety DisorderHIV/AIDSHuman Papilloma VirusHuntington's DiseaseKidney CancerMyotonic DystrophyPolycystic Kidney DiseasesPsoriasisRosaceaProstate CancerLung CancerMultiple SclerosisMultiple MyelomaDiabetes MellitusLymphomaPancreatic CancerEpilepsyCystic FibrosisLeukemiaParkinson's DiseaseInsomniaCrohn's DiseaseEndometriosisHepatitis BIdiopathic Thrombocytopenic PurpuraSjogren's SyndromeSickle Cell TraitTrisomy 21Ulcerative ColitisSystemic Lupus ErythematosusThrombotic Thrombocytopenic PurpuraPsoriatic ArthritisSpinal Muscular AtrophySickle Cell AnemiaDuchenne Muscular DystrophyOvarian CancerMelanomaSkin CancerChronic Inflammatory Demyelinating PolyneuropathyMyositisAsthmaCeliac DiseaseLupus NephritisAnkylosing SpondylitisDepressionHereditary Hemorrhagic TelangiectasiaAlopecia AreataScleroderma
NCT01931644Sanguine Biosciences17,667
Completed
Not Applicable
DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic FloridaAmyotrophic Lateral Sclerosis (ALS)
NCT01699451Mayo Clinic33